Latest News about BMY
Recent news which mentions BMY
HC Wainwright Says This Lymphoma Candidate Has Better Response Rates Than Approved Medications
June 13, 2022
From Benzinga
ASCO 2022: Surprising News in Cancer Research
June 10, 2022
From Motley Fool
U.S. companies are still making billions of dollars of adjustments to make earnings look better, study finds
June 10, 2022
From MarketWatch
7 Blue-Chip Stocks With Strong Dividend Yields
June 09, 2022
From InvestorPlace
SELLAS Life Sciences's Galinpepimut/Opdivo Combo Shows Increased Survival In Mesothelioma Patients
June 08, 2022
From Benzinga
7 Cheap Growth Stocks That Won’t Stay That Way for Long
June 06, 2022
From InvestorPlace
From Motley Fool
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
From Benzinga
From Motley Fool
From InvestorPlace
TPTX Stock Soars 115% as Bristol Myers Announces Takeover of Turning Point Therapeutics
June 03, 2022
From InvestorPlace
Is This Dividend Stock a Buy for Income Investors?
June 03, 2022
From Motley Fool
Why Pfizer Needs a High-Growth Pipeline
June 03, 2022
From Motley Fool
From Motley Fool
From Benzinga
From MarketWatch
A new generation of ulcerative colitis drugs is in development. Will they be the blockbusters that pharma wants?
May 26, 2022
From MarketWatch
Sunshine Biopharma Prepares For IND Study Of Novel Cancer Drug That It Expects Could Beat Multidrug-Resistant Cancer
May 26, 2022
From Benzinga
From Motley Fool
Michael Burry Says 2022 Is a ‘Plane Crash.’ Here’s What the Legendary Investor Is Betting On.
May 24, 2022
From InvestorPlace
From Benzinga
From Motley Fool
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.